Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2003
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/02/2003US6657052 Labeling DNA or RNA at a specific site consisting of stable precursor, and only becomes reactive upon activation; alkylating only phosphodiester groups; lactonization reaction traps the trialkylphosphate in a stable form.
12/02/2003US6656743 Human choline acetyltransferase
12/02/2003US6656730 Attached to an arylpropionic acid that interacts with human serum albumin; acid is ibuprofen, suprofen, ketoprofen, (S)-(+)- pranoprofen, or carprofen.
12/02/2003US6656689 Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003CA2276213C Method of synthesizing phosphorothioate oligonucleotides
12/02/2003CA2246909C Method for chemical synthesis of oligonucleotides
12/02/2003CA2218017C Dna sequencing by parallel oligonucleotide extensions
11/2003
11/29/2003CA2421586A1 Mucroslysin and its gene
11/27/2003WO2003097831A1 Method for nucleic acid extraction and nucleic acid purification
11/27/2003WO2003097823A1 Regulation of human serine/threonine kinase
11/27/2003WO2003097803A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097794A2 Universal-tagged oligonucleotide primers and methods of use
11/27/2003WO2003097791A2 Polynucleotide sequences encoding alkaline a-galactosidases and methods of using same
11/27/2003WO2003097688A2 Muteins of placental growth factor type 1, preparation method and application thereof
11/27/2003WO2003097687A2 Neuroprotective polypeptides and methods of use
11/27/2003WO2003097666A2 Use of gastrin releasing peptide (grp) and its receptor in cancer screening
11/27/2003WO2003097662A1 Antisense modulation of apolipoprotein b expression
11/27/2003WO2003097661A2 Antiviral phosphorothioate oligonucleotides
11/27/2003WO2003096969A2 Novel lambda phage display system and the process
11/27/2003WO2003080638A9 Antisense iap nucleobase oligomers and uses thereof
11/27/2003WO2003078589A3 Method of identifying genes controlling diferentiation
11/27/2003WO2003073980A3 Recombinant protein c variants
11/27/2003WO2003072594A3 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
11/27/2003WO2003068940A3 Complexes and methods of using same
11/27/2003WO2003067209A3 Ligands to enhance cellular uptake of biomolecules
11/27/2003WO2003064604A3 Translation profiling
11/27/2003WO2003057837A3 Methods for using anti-muc18 antibodies
11/27/2003WO2003053338A3 Novel chimeric rev, tat, and nef antigens
11/27/2003WO2003051901A3 Pseudonucleotide comprising an intercalator
11/27/2003WO2003048723A3 Label-free detection of nucleic acids via surface plasmon resonance
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002083941A3 Highly specific detection system for detecting nucleotide sequences coding for lambda and kappa light chains
11/27/2003WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/27/2003WO2002077164A3 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
11/27/2003US20030221214 Citrus tristeza virus resistance genes and methods of use
11/27/2003US20030221213 Using endogenous genetic elements to genetically enhance nutritional value and agronomic performance of plant without permanent or stable incorporation of unknown or foreign DNA into genome; reduction of freeze induced sweetening
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220486 POPS blocks are oligonucleotide regions containing alternating nucleoside phosphodiesters (PO) and nucleoside phosphorothioates (PS); improved antisense agent
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins
11/27/2003US20030220283 Including injection of a vector molecule containing the DNA sequence encoding for a product of interest, or non-viral introduction of such a DNA sequence, to one joint of a mammalian host
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219856 Comprises nucleotide sequences coding chimeric membrane proteins for diagnosing and treating cancer; antiproliferative/antitumor/antiinflammatory agents
11/27/2003US20030219816 Composite microarray slides
11/27/2003US20030219806 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
11/27/2003US20030219803 Using molecular probes for determining in situ positioning of biopolymer targets; high throughput assay
11/27/2003US20030219790 Polynucleic acid nanomechanical device controlled by hybridization topology
11/27/2003US20030219781 Compositions and methods for making polynucleotides by iterative assembly of codon building blocks
11/27/2003US20030219758 Comprises nucleotide sequences for diagnosis, prevention and treatment of metastasis, autoimmune and nervous system disorders
11/27/2003US20030219752 Preparing immunoglobulin library; high throughput assay; immunoassays; immunotherapeutics and/or diagnostics; anticarcinogenic agents
11/27/2003US20030219751 Universal-tagged oligonucleotide primers and methods of use
11/27/2003US20030219750 Schizophrenia associated genes, proteins and biallelic markers
11/27/2003US20030219746 Comprises oligonucleotide sequence for diagnosing and prognosing cancer
11/27/2003US20030219727 Prodrugs of phosphonate nucleotide analogues
11/27/2003US20030219723 Bioassys for identifying hepatitis C viricidal agents; drug screening
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219422 Polyucleotides having hammerhead motif used for detection and analysis; biosensors
11/27/2003CA2485983A1 Cancer-linked gene as target for chemotherapy
11/26/2003EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies
11/26/2003EP1364065A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof
11/26/2003EP1364048A2 Method of performing subtractive hybridization
11/26/2003EP1364032A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
11/26/2003EP1363935A2 Ter sites and ter binding proteins
11/26/2003EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro
11/26/2003EP1363660A2 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1191032B1 Dinucleotide crystals
11/26/2003EP0647280B1 Over-expression of single-stranded dna molecules
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003CN1458282A Preparing method for producing high level immunity induced by nucleic molecule and using method
11/26/2003CN1458281A Coronary virus RNA interference preparation for severe acute respiratory syndrome pathogen
11/26/2003CN1458280A Two artificial synthetic PRRS virus multiple opitope tandem pucleotide sequences and their use
11/26/2003CN1458170A New human protein with cancer inhibiting function and its encoding sequence
11/26/2003CN1458169A New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence
11/26/2003CN1458161A Process for producing human insulin using transgenic tomato
11/26/2003CN1458160A Gene recombination tumour blood vessel death factor PFK and its derivative fusion protein
11/25/2003US6653473 Fluorescent quenching detection reagents and methods
11/25/2003US6653468 Universal support media for synthesis of oligomeric compounds
11/25/2003US6653462 Nucleotide compounds including a rigid linker
11/25/2003US6653458 Modified oligonucleotides
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653106 Topoisomerase-based ligation and cloning methods
11/25/2003US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell
11/25/2003US6652808 Electric field assisted self-assembly of functionalized programmable nucleic acids, modified structures and other selective affinity or binding moieties
11/20/2003WO2003095976A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003WO2003095680A1 Methods for the enrichment of low-abundance polynucleotides
11/20/2003WO2003095666A2 Oligonucleotide probes for in vitro, in vivo and intracellular detection
11/20/2003WO2003095614A2 Cytokine polypeptides
11/20/2003WO2003095608A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/20/2003WO2003095467A1 Synthesis of locked nucleic acid derivatives
11/20/2003WO2003094835A2 Fgf variants and methods for use thereof
11/20/2003WO2003062783A3 Light addressable electrochemical detection of duplex structures
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003042401A3 Novel chromophores/fluorophores and methods for using the same
11/20/2003WO2003040344A3 Transcription factor stress-related polypeptides and methods of use in plants
11/20/2003WO2003040183A3 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
1 ... 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 ... 899